scholarly article | Q13442814 |
P2093 | author name string | H Xu | |
B D Roufogalis | |||
A J McLachlan | |||
X Jiang | |||
K M Williams | |||
R O Day | |||
M I Mohammed Abdul | |||
W S Liauw | |||
P2860 | cites work | Cranberries for preventing urinary tract infections | Q24242023 |
Possible interaction between warfarin and cranberry juice | Q24623457 | ||
Reduction of bacteriuria and pyuria after ingestion of cranberry juice | Q28248622 | ||
The effect of garlic supplements on the pharmacokinetics of saquinavir | Q33956369 | ||
Effects of garlic extract and of three pure components isolated from it on human platelet aggregation, arachidonate metabolism, release reaction and platelet ultrastructure | Q34055675 | ||
Inhibition of whole blood platelet-aggregation by compounds in garlic clove extracts and commercial garlic products | Q34556320 | ||
Interaction between warfarin and cranberry juice | Q34562224 | ||
Pomelo juice, but not cranberry juice, affects the pharmacokinetics of cyclosporine in humans | Q34565350 | ||
The role of the CYP2C9-Leu359 allelic variant in the tolbutamide polymorphism | Q34735686 | ||
Interaction of St John's wort with conventional drugs: systematic review of clinical trials | Q35615173 | ||
Warfarin and other coumarin derivatives: pharmacokinetics, pharmacodynamics, and drug interactions | Q35806425 | ||
Effect of St John's wort and ginseng on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects | Q35826093 | ||
Clinical consequences of cytochrome P450 2C9 polymorphisms | Q36002222 | ||
Interaction potential between cranberry juice and warfarin | Q36745175 | ||
Polymorphisms in the VKORC1 gene are strongly associated with warfarin dosage requirements in patients receiving anticoagulation | Q36930160 | ||
Interaction of flurbiprofen with cranberry juice, grape juice, tea, and fluconazole: in vitro and clinical studies | Q42168086 | ||
Phenylbutazone-warfarin interaction in man: further stereochemical and metabolic considerations | Q42246990 | ||
Hypocholesterolemic effect of an enteric-coated garlic supplement | Q43667350 | ||
Effects of garlic (Allium sativum L.) supplementation on cytochrome P450 2D6 and 3A4 activity in healthy volunteers | Q44532788 | ||
Warfarin and cranberry juice: an interaction? | Q44757754 | ||
A randomized trial to evaluate effectiveness and cost effectiveness of naturopathic cranberry products as prophylaxis against urinary tract infection in women. | Q45127291 | ||
The impact of CYP2C9 and VKORC1 genetic polymorphism and patient characteristics upon warfarin dose requirements: proposal for a new dosing regimen | Q46537717 | ||
Complimentary and alternative medicine use among patients starting warfarin | Q46662877 | ||
Poor correlation of supratherapeutic international normalised ratio and vitamin K-dependent procoagulant factor levels during warfarin therapy | Q46918600 | ||
Effects of daily ingestion of cranberry juice on the pharmacokinetics of warfarin, tizanidine, and midazolam--probes of CYP2C9, CYP1A2, and CYP3A4. | Q48610637 | ||
Cranberry does not affect prothrombin time in male subjects on warfarin. | Q53246232 | ||
Reduction of Bacteriuria and Pyuria After Ingestion of Cranberry Juice | Q56552172 | ||
Investigation of the Effects of Herbal Medicines on Warfarin Response in Healthy Subjects: A Population Pharmacokinetic-Pharmacodynamic Modeling Approach | Q61828246 | ||
Garlic and the risk of TURP bleeding | Q71724959 | ||
Garlic as a possible risk for postoperative bleeding | Q72379290 | ||
Platelet aggregation inhibitor in garlic | Q72450640 | ||
Differential inhibition of human platelet aggregation by selected Allium thiosulfinates | Q73213287 | ||
Interaction between paracetamol and warfarin in patients: a double-blind, placebo-controlled, randomized study | Q79404793 | ||
Can a concentrated cranberry extract prevent recurrent urinary tract infections in women? A pilot study | Q79764584 | ||
Interaction between warfarin and cranberry juice | Q81403692 | ||
Aged garlic extract may be safe for patients on warfarin therapy | Q82582261 | ||
Warfarin-cranberry juice interaction resulting in profound hypoprothrombinemia and bleeding | Q83987456 | ||
P433 | issue | 8 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | pharmacodynamics | Q725307 |
garlic | Q21546392 | ||
(RS)-warfarin | Q407431 | ||
P304 | page(s) | 1691-1700 | |
P577 | publication date | 2008-06-02 | |
P1433 | published in | British Journal of Pharmacology | Q919631 |
P1476 | title | Pharmacodynamic interaction of warfarin with cranberry but not with garlic in healthy subjects | |
P478 | volume | 154 |
Q38238911 | A Comprehensive Review of Potential Warfarin-Fruit Interactions |
Q38630265 | A systematic review of the pharmacokinetic and pharmacodynamic interactions of herbal medicine with warfarin. |
Q41762441 | Absence of pharmacokinetic and pharmacodynamic interactions between almorexant and warfarin in healthy subjects |
Q35919968 | An overview of the evidence and mechanisms of herb-drug interactions. |
Q37481442 | Antiviral drug disposition and natural health products: risk of therapeutic alteration and resistance |
Q37658866 | Clinically based evidence of drug-herb interactions: a systematic review |
Q37601361 | Complementary and alternative medicine use by otolaryngology patients: a paradigm for practitioners in all surgical specialties |
Q35810343 | Control in the middle (CIM) for three-period crossover studies |
Q38591894 | Cranberry Products for the Prophylaxis of Urinary Tract Infections in Pediatric Patients |
Q34980947 | Cranberry and urinary tract infections |
Q37399435 | Cranberry juice suppressed the diclofenac metabolism by human liver microsomes, but not in healthy human subjects |
Q35725540 | Cytochrome P450 enzyme mediated herbal drug interactions (Part 1) |
Q39785314 | Development of a bayesian forecasting method for warfarin dose individualization |
Q37848142 | Drug and dietary interactions of warfarin and novel oral anticoagulants: an update |
Q83274402 | Drug interactions with herbal medicines |
Q38175476 | Drug interactions with phytotherapeutics in oncology |
Q37054184 | Effect of cranberry dietary supplements with different brands on human CYP3A4 enzyme |
Q41907990 | Effect of high-dose cranberry juice on the pharmacodynamics of warfarin in patients |
Q34969837 | Effect of single-dose rifampin on the pharmacokinetics of warfarin in healthy volunteers |
Q34182052 | Effects of Garlic on Cytochromes P450 2C9- and 3A4-Mediated Drug Metabolism in Human Hepatocytes |
Q34306204 | Evaluation of documented drug interactions and contraindications associated with herbs and dietary supplements: a systematic literature review |
Q28076647 | Herb-drug enzyme-mediated interactions and the associated experimental methods: a review |
Q34553835 | Influence of dietary substances on intestinal drug metabolism and transport. |
Q33498604 | Interactions between herbal medicines and prescribed drugs: an updated systematic review |
Q34124444 | Interactions between herbs and conventional drugs: overview of the clinical data. |
Q34287966 | Interactions of commonly used dietary supplements with cardiovascular drugs: a systematic review |
Q27013047 | Pharmacogenomics and herb-drug interactions: merge of future and tradition |
Q89848829 | Pharmacokinetic Interactions between Cardiovascular Medicines and Plant Products |
Q38060181 | Polypharmacy and food-drug interactions among older persons: a review |
Q35062024 | Pregnancy outcome after use of cranberry in pregnancy--the Norwegian Mother and Child Cohort Study |
Q45954220 | The absence of an interaction between warfarin and cranberry juice: a randomized, double-blind trial. |
Q34494072 | The co-use of conventional drugs and herbs among patients in Norwegian general practice: a cross-sectional study |
Q38080383 | The effects of cranberries on preventing urinary tract infections |
Q34145180 | The warfarin-cranberry juice interaction revisited: A systematic in vitro-in vivo evaluation |
Q38068221 | Theranostics meets traditional Chinese medicine: rational prediction of drug-herb interactions |
Q33604138 | Therapeutic Risk and Benefits of Concomitantly Using Herbal Medicines and Conventional Medicines: From the Perspectives of Evidence Based on Randomized Controlled Trials and Clinical Risk Management. |
Q90599845 | Understanding the relevance of herb-drug interaction studies with special focus on interplays: a prerequisite for integrative medicine |
Q37686931 | Updates on the clinical evidenced herb-warfarin interactions |
Q33775460 | Use of home remedies: a cross-sectional survey of patients in Germany |
Q33630383 | Whether co-administration of garlic has negative influence on Scutellaria baicalensis Georgi in treating models rats with pelvic inflammation? |
Search more.